Alfred Wang

Alfred Wang currently serves as Vice President of Business Development & Strategy at Jade Biosciences, a position held since April 2025. Prior to this role, Alfred Wang was Vice President of Commercial Strategy & New Product Planning at Structure Therapeutics from February 2024 to April 2025 and held the title of Executive Director of Marketing & New Product Planning at Chinook Therapeutics, Inc. from January 2022 to February 2024. Alfred Wang's extensive experience includes serving as Executive Director of Commercial Strategy & Planning and Senior Director of Market Planning at Exelixis between March 2016 and February 2022. Earlier in the career, Alfred Wang worked at Gilead Sciences as Senior Manager of Pipeline Marketing Sciences / Commercial Planning and at IMS Consulting Group as Senior Consultant focused on Strategy & Portfolio Analysis. The career began at Strategic Decisions Group (SDG) as an Associate Consultant. Alfred Wang holds a PhD in Molecular Pharmacology from Stanford University School of Medicine and a B.S. in Biology from Caltech.